Profile data is unavailable for this security.
About the company
Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.
- Revenue in BRL (TTM)8.07bn
- Net income in BRL600.42m
- Incorporated1964
- Employees27.50k
- LocationFleury SAAv. Santo Amaro, 4584SAO PAULO 04.701-200BrazilBRA
- Phone+55 1 150351986
- Fax+55 1 150147425
- Websitehttps://www.fleury.com.br/
Mergers & acquisitions
| Acquired company | FLRY3:SAO since announced | Transaction value |
|---|---|---|
| GIP Medicina Diagnostica SA | 20.17% | 38.74m |
| Lsl Laboratorio de Analises Clinicas Ltda | 19.26% | 6.33m |
| Holder | Shares | % Held |
|---|---|---|
| Guepardo Investimentos Ltda.as of 17 Sep 2025 | 27.14m | 4.96% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 9.93m | 1.82% |
| Kapitalo Investimentos Ltda.as of 30 Sep 2025 | 9.30m | 1.70% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 05 Feb 2026 | 6.09m | 1.11% |
| BB Gest�o de Recursos DTVM SAas of 31 Dec 2025 | 5.73m | 1.05% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 5.47m | 1.00% |
| Ranmore Fund Management Ltd.as of 31 Oct 2025 | 5.00m | 0.91% |
| TIAA-CREF Investment Management LLCas of 31 Dec 2025 | 4.44m | 0.81% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 3.97m | 0.73% |
| Ita� Unibanco Asset Management Ltda.as of 05 Feb 2026 | 2.55m | 0.47% |
